SGLT2 Inhibitors and Mortality in Endometriosis With Type 2 Diabetes

20260 citationsJournal Articlediamond Open Access

Authors

Benjamin Marchandot · Fondation pour la Recherche Médicale

Olivier Morel · Hanoi Medical University

Mickael Guglieri · Université de Tours

Lisa Lochon · Université de Tours

Amandine Granier · Fondation pour la Recherche Médicale

Laurence Jesel · Fondation pour la Recherche Médicale

Laurent Fauchier

Abstract

Endometriosis is increasingly recognized as a systemic inflammatory condition associated with adverse cardiovascular events, yet glucose-lowering drug selection in this population is not evidence-based.

Topics & Keywords

Endometriosis Research and Treatment Coagulation, Bradykinin, Polyphosphates, and Angioedema Diabetes Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JACC Advances

DOI: 10.1016/j.jacadv.2026.102681

Field-Weighted Citation Impact: 0.00